Kalopitas, G.; Arvanitakis, K.; Tsachouridou, O.; Malandris, K.; Koufakis, T.; Metallidis, S.; Germanidis, G.
Metabolic Dysfunction-Associated Steatotic Liver Disease in People Living with HIV—Limitations on Antiretroviral Therapy Selection. Life 2024, 14, 742.
https://doi.org/10.3390/life14060742
AMA Style
Kalopitas G, Arvanitakis K, Tsachouridou O, Malandris K, Koufakis T, Metallidis S, Germanidis G.
Metabolic Dysfunction-Associated Steatotic Liver Disease in People Living with HIV—Limitations on Antiretroviral Therapy Selection. Life. 2024; 14(6):742.
https://doi.org/10.3390/life14060742
Chicago/Turabian Style
Kalopitas, Georgios, Konstantinos Arvanitakis, Olga Tsachouridou, Konstantinos Malandris, Theocharis Koufakis, Symeon Metallidis, and Georgios Germanidis.
2024. "Metabolic Dysfunction-Associated Steatotic Liver Disease in People Living with HIV—Limitations on Antiretroviral Therapy Selection" Life 14, no. 6: 742.
https://doi.org/10.3390/life14060742
APA Style
Kalopitas, G., Arvanitakis, K., Tsachouridou, O., Malandris, K., Koufakis, T., Metallidis, S., & Germanidis, G.
(2024). Metabolic Dysfunction-Associated Steatotic Liver Disease in People Living with HIV—Limitations on Antiretroviral Therapy Selection. Life, 14(6), 742.
https://doi.org/10.3390/life14060742